天地数码(300743.SZ):拟斥300万美元认购耀途资本美元基金3%份额
格隆汇4月16日丨天地数码(300743.SZ)公布,为增强公司的综合竞争力和抵御风险的能力,优化公司投资结构, 2020年4月15日,公司全资子公司港田香港与耀途控股签署了有限合伙协议及认购协议,港田香港作为有限合伙人拟以自有资金300万美元认购基金份额,投资金额占基金目标规模(1亿美元)的3%。
耀途控股成立于2019年1月21日,为该基金Glory Ventures Investments Fund L.P.的普通合伙人。耀途控股主要投资领域包括物联网与人工智能行业的底层传感器、芯片、算法、数据和存储等,应用领域包括汽车电子、消费电子、智能驾驶、金融科技、智慧安防和机器人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.